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GAG-binding variantsPreviously different authors described various ﬂavivirus mutants with high afﬁnity to cell glycosaminogly-
cans and low neuroinvasiveness in mice that were obtained consequently passages in cell cultures or in ticks.
In present study the analysis of TBEV isolates has shown existence of GAG-binding variants in natural virus
population. Afﬁnity to GAG has been evaluated by sorption on heparin-Sepharose. GAG-binding phenotype
corresponds to such virus properties, like small plaque phenotype in PEK cells, absence of hemagglutination
at pH 6.4, and low neuroinvasiveness in mice. Mutations increasing charge of E protein were necessary but
not sufﬁcient for acquisition of GAG-binding phenotype. Molecular modeling and molecular dynamics
simulation have shown that the ﬂexibility of E protein molecule could bear inﬂuence on the phenotypic
manifestation of substitutions increasing charge of the virions.
© 2009 Elsevier Inc. All rights reserved.Introduction
For wide host range viruses, like arboviruses, the ﬁrst stages of
virus–cell interaction remain unclear. It is obvious, that there are at
least three possibilities for such viruses: to use as receptors common
molecules represented on various cell types, to use distinct receptors
on different cell types or to entry cell by receptor-independent
mechanism.
Glycosaminoglycans (GAGs) are polydispense mixture of linear
polysaccharides consisting primarily of N-acetylated and N-sulphated
disaccharides arranged mainly in segregated negatively charged
domains. GAGs could be divided into: hyaluronan, chondroitin sulfate
and dermatan sulfate, heparan sulfate and heparin, and keratan
sulfate (Alberts et al., 2008). Heparan sulphate is presented on the cell
surface in the form of heparan sulphate proteoglycans (HSPGs) of
syndecan family (Gallagher et al., 1992). All ever studied cells
(excluding B-stem cells), and organs express at least one syndecan
family member (Kim et al., 1994). It has been shown previously that
heparan sulfate GAGs serve as a receptor for various viruses (reviewed
in Schneider-Schaulies, 2000). GAGs can serve as a virion concentra-
tion initial attachment molecule on the cell surface (Haywood, 1994).ll rights reserved.In most cases HSPGs are not the unique receptors involved in viral
attachment and entry processes, and virus is still able to infect cells
deﬁcient in GAG production or after GAGs removal from the cellular
membrane (Byrnes and Grifﬁn, 1998; Kroschewski et al., 2003;
Martínez-Barragán and del Angel, 2001). However, in some cases
switch of the receptor molecule (from ICAM-1 to GAG) could change
the course of infection (Khan et al., 2007). Laboratory obtained
variants with increased afﬁnity to GAGs were shown for several
viruses (Bernard et al., 2000; Heil et al., 2001; Hulst et al., 2000;
Klimstra et al., 1998; Sa-Carvalho et al., 1997). These variants were
attenuated for various animals.
Flavivirus genus gathers arthropod-transmitted viruses with virion
surrounded by lipid bilayer, which contains multiple copies of
proteins E and M, but only E protein forms outer surface. Thus, E
glycoprotein serves for viral attachment, entry and other stages of
viral penetration into the cell; besides, it's the main target for
neutralizing antibodies (Lindebach et al., 2007). E protein includes
ectodomain (sE) that is connected to the membrane by stem-anchor
region. The structure of ectodomain was ﬁrst solved by Rey and co-
authors (1995) for tick-borne encephalitis virus (TBEV) and then
were obtained structures for other genus members (Zhang et al.,
2003, 2004; Nybakken et al., 2006; Volk et al., 2006). The sE consists of
3 distinct domains: central structural domain I, domain II involved
into the process of pH-dependent membrane fusion, and receptor
attachment domain III (Rey et al., 1995).
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virus (JEV), incorporate into the target cell by clathrin-mediated
endocytosis (Chu and Ng, 2004a; Nawa et al., 2003). A lot of molecules
were described as receptors for ﬂaviviruses: integrins (Chu and Ng,
2004b; Protopopova et al., 1997), 37/67-kD high afﬁnity laminin
receptor (Protopopova et al., 1997; Thepparit and Smith, 2004),
ICAMs (Navarro-Sanchez et al., 2003; Tassaneetrithep et al., 2003),
GAGs (Goto et al., 2003; Kroschewski et al., 2003; Lee and Lobigs,
2000; Mandl et al., 2001; Martínez-Barragán and del Angel, 2001), etc.
It has been shown on TBEV that ﬂaviviruses have 2 types of receptors
on the cell surface: high- and low-afﬁnity (Maldov et al., 1992). The
role of each receptor type remains unclear, but GAGs seem to be a
widespread low-afﬁnity ﬂavivirus receptor.
GAG-binding variants were described for various Flavivirus genus
members: Yellow fever virus (YFV), Murray valley encephalitis virus
(MVEV), WNV, JEV, and TBEV. These variants were obtained during
laboratory passages in cell lines: BHK-21 (Goto et al., 2003; Mandl et
al., 2001), SW-13 (Lee and Lobigs, 2002; Lee et al., 2004), Neuro-2
(Chiou and Chen, 2007), or in ticks (Romanova et al., 2007).
Previously, about 2 dozen of increasing charge substitutions in all 3
domains of soluble part of E protein molecules of TBEV variants,
obtained during cell line passages, leading to the appearance of GAG-
binding phenotype and speciﬁc properties, were identiﬁed (Mandl et
al., 2001). The main properties were small plaque phenotype in
porcine kidney cell lines and low neuroinvasiveness for laboratory
mice. The real impact of such mutations in the E protein structural
changes has remained unknown. The existence of such variants in
natural population of ﬂaviviruses also remains unclear. TBEV strains
withmutations increasing surface charge of the virion were deposited
earlier (Ecker et al., 1999; Khasnatinov et al., 2009; Lu et al., 2008), but
their afﬁnity to cellular GAGs and other characteristics have not been
studied properly. It is natural to think that the presence of such
mutations leads to appearance of GAG-binding phenotype.
During the present work we tried to solve two main problems: to
describe afﬁnity to GAGs of natural TBEV isolates and to elucidate
whether every mutation increasing charge of E protein leads to
appearance of GAG-binding phenotype. First, we analyzed properties
of 13 pre-existing collection strains isolated in various parts of Russia
and Baltics, including sequences of E protein, plaque phenotype,
binding to heparin-Sepharose (HS), etc. Viral characteristics corre-
spondedwith increased sorption on heparin-Sepharose–GAG-bindingTable 1
TBEV strains used in present work.
TBEV strain/clone Region and year of isolation Origin of isolation
EK-328 Estonia, 1972 imago ticks I. persulca
SofjinKGGb Primorskiy kray, Far-East, Russia, 1937 brain of the patient w
205KGGb Khabarovskiy kray, Far-East, Russia, 1973 imago ticks I. persulca
80k Sverdlovsk region, Urals, Russia,
before 1970
small plaque clone of
from blood of the pat
Absettarovd Leningrad region, European part,
Russia, 1951
blood of the patient w
Absettarov 18A clone 18A of strain A
256d Belarus, before 1968 imago ticks I. ricinus
Lesopark Novosibirsk, Siberia, Russia, 1986 imago ticks I. persulca
LK-138 Lithuania, 1972 30 male imago ticks I
YuK 4/13 Kemerovo region, Siberia, Russia, 1969 1 imago tick I. persulc
DV 936k Primorskiy kray, Far-East, Russia, 1975 imago ticks H. concin
PK-36 Primorskiy kray, Far-East, Russia, 1982 1 imago tick I. persulc
Ya10/89 Yaroslavl region, European part, Russia, 1989 10 imago ticks I. pers
Ya10/89 clone 115 large plaque clone of
strain Ya10/89
Ya10/89 clone 125 small plaque clone of
strain Ya10/89
a М—passages in white mice brain; P—passages in PEK cells (Mx—passages made in mice
b Sequences of the strains obtained during the present work did not match with previousl
from published previously.
c Genotype was determined during the present work.
d Sequences of strains 256 and Absettarov obtained during the present work matched wphenotype–have been identiﬁed. It has been shown that GAG-binding
variants with complex of speciﬁc properties do exist among ﬁeld
isolates. Second, simulation of E proteins dynamics of 3 viruses has
shown that the phenotypic manifestation of substitution increasing
charge of E protein molecule depends on amino acid context, and not
every such mutation is sufﬁcient for the appearance of the GAG-
binding phenotype. Furthermore, we have shown that structural
inﬂexibility of E protein molecule is highly involved in appearance of
GAG-binding phenotype and complex of relevant properties.
Results
Plaque phenotype of studied TBEV strains
Previously, it was shown that one of the features of GAG-binding
variants was small plaque phenotype in porcine kidney cell lines
(Mandl et al., 2001; Romanova et al., 2007). First we described plaque
size in PEK cells under agar overlay on the 8th day of infection for all
collection strains (Table 1). All results are summarized in Table 2.
Strains Absettarov, 256, LK-138, YuK 4/13, SofjinKGG, 205KGG, DV
936k, EK-328, Lesopark, formed large plaques. Strain 80k formed
small plaques, less than 1mm in diameter. Strain PK-36 formed
plaques of middle size, 3–6 mm. The large and middle plaques
appeared on 3–4 days p.i. and reached 7–10 mm in size by the 7–
8 days of infection. In contrast, small plaques appeared only on days
6–7, and practically did not increase in size during the period of
observation.
Strain Ya10/89 formed plaques heterogeneous in size. Possibly,
this was due to mixing of different viruses from 10 different ticks
prepared in one single isolate or true heterogeneity of the isolate. For
following investigations we isolated from plaques clones 115 and 125
with plaque sizes of 8 and 1 mm in diameter, respectively.
Strain Absettarov formed plaques from 8 to 10 mm in diameter.
From this population was plaque-puriﬁed clone 18A. The clone 18A
showed plaques a bit smaller than parental strain ones: 7.3±0.7 mm
vs. 9.5±1 mm (ptb0.0001).
Analysis of TBEV strains and clones sorption on heparin-Sepharose
Small plaque size could be explained by several features, including
virus inability to reproduce efﬁciently in the cell culture (low rate orPassagesa GenBank number Subtype
tus M6P1M2P1-2 DQ486861 Siberian
ith acute TBE; cloned Mx and P2-5 after cloning GU121963 Far-Eastern
tus МN20P1 GU121964 Far-Eastern
strain 80, isolated
ient with acute TBE
Mx andМ5P1 after cloning GU121965 Far-Easternc
ith TBE МN20P1 AF091005 European
bsettarov P4 after cloning –
МN20P1 AF091014 European
tus МxM4P1-2 GU121966 Siberianc
. ricinus M2P1-2 GU125720 Europeanc
atus M4P1-2 GU125721 Siberianc
a M2P1-2 GU125722 Far-Easternc
atus M2-6P1 GU121967 Far-Easternc
ulcatus P1-4 – –
heterogeneous P1-2 – Siberianc
heterogeneous P1-2 GU125719 Siberianc
brain by the strain authors before they were received in our laboratory).
y GenBank published sequences; we added abbreviation KGG to distinguish our strains
ith GenBank published sequences.
Table 2
Biological, immunochemical and virological properties of TBEV strains.
TBEV
strain/clone
Plaque size
(mm)
Virions bound to HSa Cathode
precipitate
in RIEc
Amino acid
substitution
in E proteind
Number of
experiments
Sorptionb
Absettarov 9.5±1.0 2 − + −
Absettarov 18A 7.3±0.7 4 − + Asp67→Gly
256 8.3±0.9 3 − + −
LK-138 9.2±0.8 1 − + −
EK-328 7.0±0.5 3 − + −
Lesopark 8.0±1.5 3 − + −
YuK 4/13 11.3±1.8 1 − + −
Ya10/89 1.0:2.5
(45:1e)
nd nd + nd
Ya10/89 c.115 8.0±0.5 1 − + −
Ya10/89 c.125 1.0±0.5 1 + − Glu122→Gly
SofjinKGG 8.0±0.9 2 − + −
205KGG 9.0±1.5 4 − + −
80k 1.0±0.5 4 + − Asp67→Asn,
Thr68→Ala
DV 936k 10.0±0.5 1 − + −
PK-36 4.5±2.0 1 − + −
a HS—heparin-Sepharose.
b ‘+’—sorption on HS is over 90%, ‘−’—sorption on HS is less than 70%.
c RIE—rocket immunoelectrophoresis; ‘+’—presence of cathode-pointed precipitate
of virions with antibodies, ‘−’—absence of cathode-pointed precipitate of virions with
antibodies.
d Mutation was marked in comparison with relevant genotype consensus, with
parental strain Absettarov for Absettarov 18A, with Ya10/89 clone 115 for Ya10/89
clone 125, in comparison with Far-Eastern consensus for strain 80k; ‘—’ is used to mark
the absence of such mutation.
e The ratio of small plaques (1mm) to bigger ones (2.5mm).
Fig. 1. TBEV strains sorption on heparin-Sepharose. The percentage of sorbed virus was
determinedasHS-sorbedvirus to control S-unsorbedvirus ratioevaluatedbyplaqueassay.
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increased virion sorption on the cellular negatively charged proteo-
glycans and/or agar sulphopolysaccharide heads, etc. The latter could
be described like newly formed virions binding to sulphogroups of the
neighboring cell GAGs and/or agar that prevent virus diffusion far
from the primary infected cell.
To evaluate the strains' afﬁnity to heparan sulphate GAGs we used
common model of the process—binding to heparin-conjugated
Sepharose beads. Virus was incubated with HS and S beads and the
amount of unsorbed virus was determined by plaque assay, then the
ratio HS-sorbed to control S-unsorbed virus was calculated.
Both small plaque forming TBEV variants (80k and Ya10/89 clone
125) showed signiﬁcantly increased afﬁnity to HS (over 90% of sorbed
virions) (Table 2 and Fig. 1) in comparison to large plaque strains (0–
25%). Thus, all small plaque virus variants had GAG-binding phenotype.
Strain PK-36 with middle plaque size had middle HS sorption activity
(about 60%).Fig. 2. RIE for several TBEV strains: (tracks) 1—strain SofjinKGG; 2—strain Lesopark; 3—
strain EK-328; 4—Ya 10/89 clone 125; 5—Ya 10/89 clone 115; 6—strain 205KGG; 7—
strain 80k; 8—strain Absettarov; 9—strain 256. Arrows pointed on the rockets of anode-
pointed non-virion antigen (oligomers of secreted NS1 protein) and cathode-pointed
virion antigen.Rocket immunoelectrophoresis (RIE) behavior of studied TBEV strains
and clones
Previously, TBEV virions behavior in RIE was described by
Liapustin et al. (1987), Dzhivanian et al. (1991) and Romanova et al.
(2007). In RIE buffer system TBEV virions have weak negative charge,
and should remain still or slowly drift towards anode in electric ﬁeld.
Upon high endosmosis in agarose virions move towards the cathode
and form cathode-pointed rocket of precipitate with antibodies—
virion antigen. The oligomeric forms of secreted NS1 protein in culture
ﬂuid have strong negative charge and small size in comparison with
the virion. So, in spite of endosmosis, NS1 forms an anode-pointed
rocket—non-virion “soluble” antigen (Fig. 2).
For RIE experiments viruses were normalized by titer (6–7 log10
PFU) in infected cell culture ﬂuid. RIE results are summarized in Table
2 and Fig. 2. Virions of all large and middle plaque strains formedcathode-pointed precipitate with antibodies in RIE. Virions of the
small plaque strains did not produce such precipitate.
Increased afﬁnity to agarose sulphopolysaccharide heads could
explain the inability of virions of GAG-binding variants to form
cathode-pointed rocket in RIE. Precipitation of virions by antibodies
requires dense arrangement of virions at a distance comparable with
the size of the immunoglobulin molecule, which could be achieved in
the case of dense motion of virions towards the cathode in electric
ﬁeld. An increase of the charge of virions can promote their binding to
agarose sulphogroups in the gel. In this case, virions would move not
as a dense front, but as a diffuse smear, which would prevent a
sufﬁcient concentration of virions in any part of the gel, and
subsequently avert formation of immunoprecipitate.Hemagglutinating activity (HA) of studied TBEV strains and clones
Previously, described GAG-binding variants did not provide
noticeable HA in pH 6.4 or the optimal pH was moved to pH 6.6
Table 4A
Virulence of selected TBEV strains in BALB/c mice.
TBEV strain/clone GAG phenotypea Virulence LD50 (log10PFU) after i.p.b
Absettarov − 0.4
Absettarov 18A − 2.0
256 − −2.0
EK-328 − 1.0
Lesopark − 1.4
Yar10 c.115 − 2.0
Yar10 c.125 + 2.9
Sofjin KGG − 1.6
80k + 3.8
a ‘−’—virus without GAG-binding phenotype, ‘+’—virus with GAG-binding
phenotype.
b i.p.—upon intraperitoneal inoculation.
Table 4B
Virulence of selected TBEV strains in outbred mice.
TBEV strain/clone GAG phenotypea Virulence LD50 (log10PFU)
after i.c.b after i.p.c
Absettarov − −2.7 −1.4
Absettarov 18A − 1 2.2
EK-328 − 0.7 ndc
Sofjin KGG − −0.8 1.2
205KGG − nd 1.6
80k + 0.4 2.8
a ‘−’—virus without GAG-binding phenotype, ‘+’—virus with GAG-binding
phenotype.
b i.c.—upon intracerebral inoculation, i.p.—upon intraperitoneal inoculation.
c nd—not done.
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hemagglutination of goose erythrocytes with 2-fold dilutions of
infected cells supernatant aliquots in range pH 5.7–7.0 (pH 5.7, 6.0,
6.2, 6.4, 6.6, 6.8, 7.0). Results are summarized in Table 3.
Studied strains differed in pH range with noticeable HA. Thus,
strain EK-328 agglutinated erythrocytes at pH 5.7–7.0 and strain
205KGG showed HA only in pH 6.2–6.4. Nevertheless, all large and
middle plaque viruses, excluding clone Absettarov 18A, were able to
hemagglutinate at optimal pH 6.4. Clone 18A showed sufﬁciently high
HA, but the optimal pH was moved from 6.4 to acid values (pH 6.0).
GAG-binding variants differed from other strains in HA absence at pH
6.4. Strain 80k did not provide any noticeable HA in all pH values, and
clone 125 of Ya10/89 exhibited light HA at pH 7.0.
Virulence of TBEV strains and clones in mice
Various authors showed that GAG-binding variants of ﬂaviviruses
had low neuroinvasiveness (Goto et al., 2003; Lee and Lobigs, 2002;
Lee et al., 2004; Mandl et al., 2001; Romanova et al., 2007).
To evaluate the neuroinvasiveness BALB/c mice were chosen as
susceptible to TBEV infection (Pletnev et al., 2000). To estimate the
reliability of the neuroinvasiveness test differences for distinct viruses
we had to know the variability of results from experiment to
experiment. For this purpose we chose 2 of investigated viruses—
strain Absettarov and strain EK-328 for detailed study and processed
obtained results statistically. For strain Absettarov series of 16
independent experiments was provided. LD50 after i.p. inoculation
was 0.4±0.2 log10PFU (SD=1.0 log10PFU). For strain EK-328 were
provided 3 independent experiments. Neuroinvasiveness was 1.0±
0.5 log10PFU (SD=0.8 log10PFU). We decided to use 0.5 log10PFU as
standard error for all other obtained results.
Neuroinvasiveness on BALB/c mice differed a lot among studied
TBEV strains from−2 log10PFU for strain 256 to 3.8 log10PFU for strain
80k (Table 4A). Neuroinvasiveness of both small plaque GAG-binding
variants–80k and Ya10/89 clone 125–was signiﬁcantly lower in
comparison with other strains. The difference was the most visible in
comparison of viruses of one subtype, like 80k vs. SofjinKGG; Ya10/89
clone 125 vs. clone 115, strains EK-328 and Lesopark. The neuroinva-
siveness of clone Absettarov 18A was lower than the parental strain
one (Absettarov 18A vs. Absettarov).
Low neuroinvasiveness could be due to inability of virus to invade
CNS and/or to kill CNS cells. To elucidate this we obtained i.p. and i.c.
values for several strains on outbred mice less susceptible for TBEV
than BALB/c mice (Table 4B). Strains signiﬁcantly differed in
neurovirulence from −2.7 log10 PFU for strain Absettarov to 0.7
log10 PFU for strain EK-328. Neuroinvasiveness results in outbredTable 3
Hemagglutinating activity of investigated TBEV strains.
Virus Titer
(lgPFU/ml)
Allowed of
pH range
Optimal
pH
Titer HA in
optimal pH (log2)
Absettarov 6.7 5.7–6.4 6.4 6
Absettarov 18A 7.2 5.7–6.4 6.0 5
256 5.2 5.7–6.8 6.4 8
LK-138 7.1 5.7–6.4 6.4 4
EK-328 7.8 5.7–7.0 6.4 9
Ya10/89a 6.9 ndb nd 5
Ya10/89 c.115 7.4 6.4–7.0 6.4 3
Ya10/89 c.125 7.5 7.0 7.0 1
SofjinKGG 6.3 6.2–6.6 6.4 10
205KGG 7.7 6.2–6.4 6.2–6.4 3
80k 6.9 – – –c
DV 936k 8.1 6.2–7.0 6.4–6.8 3
PK-36 6.0 5.7–6.6 6.4 8
Titer of HA was determined in culture ﬂuid of infected PEK cells.
a HA was determined only in pH6.4.
b nd—not done.
c Absence of HA in minimal dilution at all pH values.mice corresponded to the ones in the BALB/c mice. Strain 80k and
clone Absettarov 18A were the least virulent for outbred mice upon
peripheral inoculation than other investigated strains. Clone 18A
virulence upon i.c. and i.p. inoculation was 5000-fold and 4000-fold
lower than parental strain ones, respectively. Thus, clone 18A
neurovirulence and neuroinvasiveness both decreased on the same
level in comparison to the parental strain. Strain 80k neuroinvasive-
ness was 40-fold lower than the one of strain SofjinKGG, and
neurovirulence was only 16-fold lower than the one of SofjinKGG.Sequencing of E protein genes of TBEV strains and clones
We obtained nucleotide sequences of part of viral genome
encoding E glycoprotein (or sE part of the glycoprotein) of collection
TBEV variants. Using these sequences we analyzed amino acid
substitutions leading to increase of the surface charge of the E protein
molecule in comparison with consensus sequence of the relevant
genotype.
Investigated TBEV strains represented all three subtypes: Europe-
an (Absettarov, 256, LK138), Siberian (EK-328, Lesopark, YuK4/13,
clones of Ya10/89), and Far-Eastern (SofjinKGG, 80k, 205KGG,
DV936k, PK-36).
Both GAG-binding viruses showed amino acid substitutions increas-
ing surface charge of the E protein molecule (Table 2). Strain 80k had
Asp67→Asn, in comparison to the consensus of Far-Eastern genotype.
Besides, strain 80k carried additional mutation in Thr68→Ala. Small
plaque clone 125 of strain Ya10/89 carried Glu122→Gly in comparison
with clone 115 and Siberian genotype consensus. In addition,
sequencing revealed 2 nt synonymic substitutions in 1600 nt between
clones of strain Ya10/98. Moreover, we found out the clone Absettarov
18A surprisingly carried Asp67→Gly mutation, similar to strain 80k, in
comparison to the parental strain.
All other TBEV variants didn't show any charge increasing
substitutions in comparison to the genotype's consensus sequences.
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Finally, we decided to elucidate why clone 18A of strain Absettarov
with substitution increasing charge of the E protein molecule hadn’t
changed its GAG afﬁnity. To solve the problem we chose for further
investigations viruses Absettarov 18A, carrying charge-increasing
substitution in 67 amino acid position of E protein that didn’t affect
the virus properties, strain 80k, as GAG-binding variant carrying
analog substitution in the same position, and strain SofjinKGG, as a
strain of Far-Eastern subtype.
We built models of soluble domain of E protein molecule for
Absettarov 18A, SofjinKGG and 80k on the basis of strain Neudorﬂ (PDB
access code 1SVB). The difference between the template and target
proteins was subtle (Fig. 3); no insertions or deletions occurred in the
alignment and only local substitutions were present. 12 substitutions
differed in Western and Far-Eastern genotype strains (47, 88, 115, 120,
178, 206, 260, 267, 277, 317, 331, 363 residues). Strain Absettarov
differed from strain Neudorﬂ in only 1 amino acid in position 167 (Ile to
Val), and clone 18A differed from parental strain in position 67 (meant
above). 2 amino acids in addition to 2mutationsmarked above differed
strain 80k from strain SofjinKGG (Thr4→ Ile, Ala153→Val). Although,
the main difference between strains occurred around position 67.
Strains Neudorﬂ and SofjinKGG contained Asp67, clone 18A carried
Gly67, and strain 80k had Asn67, and additionally Thr68→Ala.
The charge distribution for themean structure of modeled proteins
is shown in Fig. 4A. One could easily see that the surface charge
distribution for the protein E of all strains was very similar. It was
obvious for the strains 80k and Absettarov 18A due to the character of
the amino acid substitutions, but for SofjinKGG such observation was
less expected. Namely, net charge of the protein from strains
Absettarov 18A and 80k equaled −2, whereas for the protein from
strain SofjinKGG it was equal to−4. The negative charge of the latter
protein was located mainly at the membrane side of the protein (data
not shown). Although the ridge formed by amino acid side chains
exposed on the external surface across 2 subunits of the E protein
dimer slightly differed on the surface charge distribution map. These
amino acids could be possibly involved into electrostatic interactions
with molecules on cellular membrane, like GAGs.
Nevertheless, static representation of the proteins obtained by
modeling was not sufﬁcient to explain the differences in properties of
Absettarov 18A and strain 80k.
We collected 10 ns trajectories for TBEV variants under consider-
ation—Absettarov 18A, SofjinKGG and 80k. Principal component
analysis revealed two main components of the protein movement
during molecular dynamics simulation: (1) twist around the longest
dimer axis I, and (2) bending around the axis II (Fig. 4B). For all cases
the movement of the protein could be characterized by its bending.
According to this observation, we had chosen the bending angle (b.a.)
instead of root-mean-square distance (RMSD) as the main variable
describing the conformation of the protein during dynamics. We had
also built correlation maps with the aim to understand the possible
correlated motions of the protein parts.
The simulation started from the planar conformation (b.a. ca.
180°) corresponded to the crystal structure of the template, and then
during the ﬁrst nanosecond bending was initiated by the thermal
motion of the molecule. The bending angle dependence on time is
presented in Fig. 4C. There were no signiﬁcant differences between
the strains which could illuminate the distinction between the HS-
binding properties of three proteins.
We had built correlation maps (Fig. 4D) with the aim to describe
correlatedmotions of the proteins. Thesemaps were rather similar for
all the proteins, but notable differences did exist. The domains
showed strongly correlated movements inside the domain and
negative correlation between domain II (residues 52–136 and 190–
284) and other domains. The movement of domain I (residues 1–51,
137–189 and 285–302) possessed moderate correlation with themovement of domain III (residues 303–395). For clone Absettarov
18A and strain SofjinKGG a stronger correlation was observed inside
the domain II compared to the strain 80k. The movement of domain I
was more distorted for strain 80k, with regions of correlation and
anti-correlation being more noticeable than for two other strains,
especially in the region of residues 137–189.
Summarizing our simulation studies, we could say that the
dynamic behavior of the strain 80k E protein differed from that of
the clone Absettarov 18A and strain SofjinKGG. The difference was
rather small due to very high identity of amino acid sequences of these
proteins, but it was marked enough to be a working hypothesis for
explanation of the experimental results.
Discussion
Interest for GAG-binding variants derives from several facts: (1)
one amino acid substitution corresponds to complex of peculiarities
typical for GAG-binding phenotype; (2) there could be several sites on
the one protein responsible for GAG-binding phenotype appearance,
and position of themutation could inﬂuence the intensity of display of
obtained variant properties; (3) change of afﬁnity to GAGs could
modulate virus cell tropism; (4) low neuroinvasiveness; (5) high
potential for emergence of genetic variability for virulent variants, as
set of various mutations compensating increased charge of E protein
and restoring virions low afﬁnity to cellular GAGs and, thus, increasing
virulence, could appear. The existence of such variants for wide range
of viruses indicates that different viruses could use the same
mechanism to change population properties.
Previously, laboratory obtained GAG-binding variants were de-
scribed for various ﬂaviviruses, including TBEV (Chiou and Chen,
2007; Goto et al., 2003; Lee and Lobigs, 2002; Lee et al., 2004; Mandl
et al., 2001; Romanova et al., 2007). During the present study we
monitored 13 collection TBEV strains and found two containing GAG-
binding variants. Therefore, we have provided evidence that GAG-
binding variants do exist in natural TBEV population using the virus
(clone 125 of Ya10/89) with short laboratory passage history and
strain (80k), and could be isolated from different origins, like tick
suspension or blood of patient with acute TBE. In the present work on
natural strains we have supported our data obtained earlier for
laboratory virus variants, that GAG-binding phenotype, i.e. increased
sorption on HS, corresponded to such virus properties, like small
plaques in PEK cells, absence of HA activity at pH 6.4 and cathode-
pointed precipitate of virions with antibodies in RIE, low neuroinva-
siveness in mice (Romanova et al., 2007). In the case the properties
like HS-sorption, HA and precipitate forming in the RIE are
determined only by E protein, and the properties like plaque size or
neuroinvasiveness could be due to involvement of some other viral
proteins activities. Previously, by methods of reverse genetics was
shown that mutation Glu122-Gly, the same as in Ya10/89 clone 125,
and Asp67-Gly, analogous to the one in strain 80k, deﬁned the GAG-
binding phenotype (Khasnatinov et al., 2009; Mandl et al., 2001).
Summarizing all the data we can consider that the complex of
properties indicates the GAG-binding variants.
Previously, the set of various mutations increasing virion charge
have been described TBEV during virus propagation in cell culture
(Goto et al., 2004; Mandl et al., 2001) or in ticks (Labuda et al., 1994;
Romanova et al., 2007). Besides, it has been shown that TBEV can exist
as stable heterogeneous population containing variants with different
afﬁnity to GAGs (Romanova et al., 2007). Both GAG-binding variants
(strain 80k and Ya10/89 clone 125) described in the present study
were cloned from primary isolate to investigate exactly the small-
plaque variants: original strain 80 was described by the author as
large plaque and parental strain Ya10/89 exhibited heterogeneous
plaque phenotype. According to the data presented here and
published previously of the existence of TBEV strains with E protein
charge increasing mutations (Ecker et al., 1999; Khasnatinov et al.,
Fig. 3. Alignment of E protein ectodomain of studied viruses (strain Absettarov, clone Absettarov 18A, strain SofjinKGG, strain 80k) and strain Neudorﬂ, used as a template for modeling structures.
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Fig. 4. (A) Surfaces of the E protein models colored according to electrostatic potential. S—strain SofjinKGG, 80—strain 80k, A—clone Absettarov 18A. The color ramp of electrostatic
potential is in the left; red corresponds to the most positively charged regions, blue—to the most negatively charged. White square encloses residue 67. (B) Overview of the model of
the E protein for the clone Absettarov 18A. Domain I is red, domain II is yellow, domain III is blue. Axis I is the axis of the twist motion, axis II corresponds to bendingmotion. Residues
Lys64, Ser66, Gly67, Thr68, Lys69, Glu84, Thr90, Lys118 and Glu122 are shown. (C) Plot of bending angle (degrees) dependence on time (ps) for E proteins of 80k (orange),
Absettarov 18A (green), and SofjinKGG (purple). (D) MD simulation correlation maps. On the X and Y axes amino acid residues of monomers of E protein dimer are situated
consequently. The dot on the map symbolizes the motion of X axis residue relative to Y axis residue. The highest correlation corresponds to yellow regions, the lowest—to blue.
268 L.I. Kozlovskaya et al. / Virology 398 (2010) 262–2722009; Lu et al., 2008) or with complex of speciﬁc properties described
above (Chunikhin et al., 1986; Pogodina et al., 1992) we can assume
that GAG-binding variants exist like an admixture in natural TBEV
population that is hardly seen.They showed that GAG-binding variants could appear during TBEV
adaptation to ticks: European strain to Ixodes ricinus ticks (Labuda et al.,
1994), or Siberian strain to Hyalomma marginatum marginatum ticks
(Romanovaet al., 2007), or several strains (including Far-Eastern strain)
269L.I. Kozlovskaya et al. / Virology 398 (2010) 262–272toHyalomma anatolicum ticks (Chunikhin et al., 1986). According to the
data of reproduction rate of GAG-binding variants (Romanova et al.,
2007) or of genetically constructed variants with charge increasing
mutation in E protein (Khasnatinov et al., 2009) in tickswe can consider
that such variants have selective advantage during reproduction in tick
organism, apparently, regardless of tick species.
Several cell lines, like BHK-21, SW-13, Neuro-2, used for virus
isolation, were predisposed to select virus variants with increased
afﬁnity to cellular GAGs (Lee and Lobigs, 2002; Lee et al., 2004; Mandl
et al., 2001). Thus, GAG-binding variants appearing even after short-
term passages in these cultures could be novel adaptive or preexist-
ing. However, mutants with decreased afﬁnity to cellular GAGs could
appear in population of GAG-binding virus during infection in
mammalian host or in PEK cells (Chunikhin et al., 1986; Kaluzová et
al., 1994; Liapustin et al., 1987; Romanova et al., 2007). Only one
substitution has been sufﬁcient to switch the phenotypic character-
istics of GAG-binding variants (Romanova et al., 2007). So, passages in
laboratory animals or some cells could lead to practically total
elimination of GAG-binding variants from natural isolate. In the
present work both GAG-binding variants were propagated in PEK cells
that allowed us to assume that they preexisted in natural isolate
because it was shown previously the cell line didn’t lead to
appearance of adaptive mutations increasing afﬁnity to GAGs
(Romanova et al., 2007). Strain 80k didn’t change through long-
term laboratory passaging and never produced plaques of heteroge-
neous phenotype (data not shown). Probably, this could be explained
by speciﬁc composition of two neighboring mutations (Asp67→Asn,
Thr68→Ala) in the E protein that make speciﬁc efﬁcient conformation
of the molecule, and mutations would be crucial for virus viability.
Amino acid mutations in domain II of E protein could affect on HA
and fusion activities changing low-pH-triggered dimer–trimer con-
formational switch (Allison et al., 1995; Heinz and Allison, 2000). In
the present study both GAG-binding variants, carrying substitution in
the domain II of E protein, lost their hemagglutinating activity. All
large and middle plaque viruses, excluding clone Absettarov 18A,
hemagglutinate erythrocytes at optimal pH 6.2–6.4. Gaining of
mutation in E protein domain II of viruses meant above led them to
narrow the range of allowed pH for HA and drastically moved the
optimal pH. Strain 80k absolutely lost ability to HA, Ya10/89 clone 125
was able to agglutinate erythrocytes in minimal dilution at pH 7.0. In
contrast to strain 80k, Absettarov 18Awith analogmutation sustained
HA property, although optimal pH was a bit shifted. Lately the strain
Yar 46-2 with the same mutation as the one of clone 18A was
described and the strain had no ability to HA (Khasnatinov et al.,
2009). It is obvious that HA decreasing or absence associates exactly
with GAG-binding phenotype, rather than with just presence of
mutation increasing charge or hydrophobicity of E protein.
In our work both GAG-binding variants Ya10/89 clone 125 and
strain 80k showed lowed neuroinvasiveness. Previously, we described
the tick-adapted variant M, obtained from strain EK-328, with
increased sorption on HS (N90%) and low neuroinvasiveness
(LD50=5.4 log10 PFU). Ya10/89 clone 125 with the same mutation
like variant M had LD50=2.9 log10 PFU, lower in comparison with
large plaque clone 115, but signiﬁcantly higher than variant M's one.
On the one hand, this indicates that such substitution is important for
TBEV virulence. On the other hand, increased sorption on cellular
GAGs decreases neuroinvasiveness, nevertheless, since neuroinva-
siveness is a multi-determinative process, the virulence could due to
involvement of other reactions in vivo determined by other viral
properties. In case of clone 18A with low afﬁnity to HS and
substitution in position 67 showed drastically decreased neuroviru-
lence and neuroinvasiveness in comparison with parental strain, but
still higher than the ones of the GAG-binding variants. It could be
explained that the mutation in Absettarov 18A E protein does not
provide enough impact on the molecule structure to switch the HS
afﬁnity. It could be interpreted that not every E protein chargeincreasing substitution is sufﬁcient for HS-afﬁnity switch but is
enough for decreasing virulence in mice through inﬂuence on
sorption on other receptors or other GAG types, for example,
chondroitin sulfate on the CNS cells. Besides, the Asn67 in the E
protein molecule of strain 80k is typical for hemorrhagic ﬂaviviruses
(Barker et al., 2009). Therefore, lowed neuroinvasiveness of the virus
could be due to switch of susceptible cell type preference.
The present work provides evidence that not every mutation
increasing net charge of the E protein molecule leads to appearance of
the new virus with GAG-binding phenotype and all complex of
speciﬁc properties. The analysis of electrostatic potential distribution
on the surfaces of the E proteins of Absettarov 18A, 80k and Sofjin
revealed only slight differences. According to Mandl and co-authors
(2001) most of the mutations increasing afﬁnity to GAGs lay on the
surface of domains I and II of E protein. Similarly, there is a visible
ringe formed by side chains of amino acids of domains I and II of 2
connected subunits in dimer on electrostatic potential maps, obtained
during homology modeling. In case of SofjinKGG this ringe include
more negatively charged sites than in case of Absettarov 18A or 80k.
Although, surface charge distribution difference does not explain
distinct properties of clone Absettarov 18A and strain 80k.
Correlation maps based on MD trajectories showed striking
differences between E proteins of these 3 viruses. The comparison
of SofjinKGG and Absettarov 18A maps in common shows the
genotype differences of correlated movement inside E protein
molecule.
Comparison of the correlation map of the 80k with 2 other maps
could explain the dramatic contrast of its properties. The protein of
strain 80k seems being divided into small grains, whereas domains of
the protein of strains Absettarov 18A and SofjinKGG move as a whole.
Consequently, the protein of strain 80k is less tight than the one of
two other strains, and highermobility of small parts of the protein can
be the reason for higher HS binding afﬁnity. Because distinct surface
residues of 80k E protein move more independently from each other
that, probably, allows them to interact freely with HS and cellular
membrane molecules.
Previously, all described variants with GAG-binding mutation
were selected by exhibited phenotype, like plaque size. That could
explain why variants, like Absettarov 18A, remain unnoticed.
Although, such variants with pre-existing mutation that in some
circumstances could lead to formation of novel GAG-binding variants
may store in virus population for long periods of time and through
virus transmission lifecycle. As far as Absettarov 18A is one of the
plaque-puriﬁed clones of strain Absettarov, so we can propose it to
long-term maintenance through laboratory passaging of the whole
strain. Thus, such variants could survive silently, hiding its pre-
existing mutation, in the virus population.
Thus, GAG-binding variants (with increased afﬁnity to HS) with
complex of peculiarities, like small plaque phenotype in PEK cells,
absence of HA at pH 6.2–6.4, absence of cathode-pointed precipitate
in RIE, low neuroinvasiveness, do exist in natural TBEV population.
Even though, not every amino acidmutation increasing surface charge
of E protein molecule leads to appearance of GAG-binding phenotype.
According to obtained data we can suppose that the ﬂexibility of E
protein molecule could inﬂuence virion–GAG interactions.
Materials and methods
Cells and viruses
Pig embryo kidney (PEK) cell line was maintained at 37 °C in
medium 199 (PIPVE, Russia) supplemented with 5% bovine serum
(Furo, Russia).
TBEV strains used in the work are summarized in Table 1. Strain
Lesopark and the virus containing tick suspension from where strain
Ya10/89 was isolated were kindly provided by Dr. N.G. Bochkova and
270 L.I. Kozlovskaya et al. / Virology 398 (2010) 262–272Dr. V.V. Pogodina (Chumakov IPVE RAMS). Cloned strain 80k was
received from one of strain author Dr. V. Kolotvinov.
Viruses were stored as aliquots of 10% infected mouse brain
suspensions or infected PEK cell culture ﬂuids at −70 °C.
Plaque assay
The procedure of plaque assay was described previously (Roma-
nova et al., 2007). Brieﬂy, PEK cells were seed in 6-well plates
(Corning) and incubated for 72 h at 37 °C in CO2-incubator. 10-fold
dilutions of virus samples were prepared on medium 199. Equal
aliquots of viral suspensions were added to each well in 1–3 parallels,
and incubated in CO2-incubator for 1 h with gentle shaking. Then,
each well was overlaid with 5 ml of 1% agar (Difco) on Earle solution
containing 7.5% FBS and 0,015% neutral red. After incubation at 37 °C
in CO2-incubator plaques were counted everyday till day 14 of
infection. The virus titer was calculated and expressed as the log10
plaque forming unit (PFU) per ml.
Virus hemagglutination (HA)
Hemagglutination of the TBEV strains was assayed with goose
erythrocytes according to the standard protocol (Clarke and Casals,
1958) in 2 parallels for each sample dilution in pH 5.7–7.0.
Virulence in mice
All experiments were carried out in 10- to 12-week-old BALB/c
(Stolbovaya, Moscow region, Russia) or outbred (Andreevka, Moscow
region, Russia) mice. TBEV strains were evaluated for both neuro-
virulence by intracerebral (i.c.) inoculation (30 μl) and neuroinva-
siveness by intraperitoneal (i.p.) inoculation (300 μl). Mice in groups
of six were injected with 10-fold dilutions of virus and observed for
clinical symptoms for 21 days after inoculation. LD50 was calculated
according to the Kerber method (Lorenz and Bogel, 1973).
Sequencing
Viral RNA was extracted from 10% brain suspensions or from PEK
cell culture supernatants by TRIReagent LS (Sigma) according to the
manufacturer's instructions. Reverse transcription was carried out
with M-MLV reverse transcriptase (Promega, Madison, WI) according
to the manufacturer's protocol. Viral genome cDNA was ampliﬁed by
PCR using overlapping sets of TBEV speciﬁc primers (primer
sequences available upon request). Sequencing was carried out
directly from PCR DNA in both directions on the ABI PRISM 3730
(Applied Biosystems) sequencer using ABI PRISM® BigDye™ Termi-
nator v. 3.1. The sequences were aligned with Clustal-X 2.0.11 (Larkin
et al., 2007). Genotype was determined according to the phylogenic
analysis.
Virus binding to heparin-Sepharose
The binding assay of TBEV on heparin-Sepharose beads was
performed as described earlier (Romanova et al., 2007) with some
modiﬁcations. Brieﬂy, 0.5 ml of a 50% heparin-Sepharose CL 6B
(Pharmacia) suspension in 199 medium, pH 7.6, was spun down.
Virus suspension (0.5 ml containing 4–5 log10 PFU) was added to the
heparin-Sepharose (HS) pellet, mixed thoroughly, and incubated for
1 h at 37 °C with occasional vigorous shaking. Control viruses were
treated similarly with Sepharose CL 6B (Pharmacia) to take into
account the matrix sorption. After the binding step, heparin-
Sepharose and Sepharose was pelleted by centrifugation, and the
supernatant was collected and tested for presence of unsorbed virus
using plaque assay in PEK cells. Binding efﬁcacy was determined as a
percentage of sorbed virus (S-unsorbed virus minus HS-unsorbedvirus) to the control virus titer. The viruses were tested for HS binding
in 1–4 separate experiments with 2 parallels in each experiment. To
decrease the variability of plaque assay results titration was provided
in 2–4 parallels for each sample dilution.
Rocket immunoelectrophoresis (RIE)
RIE was carried out in 1% high endosmosis agarose (Serva) in
barbiturate-barbital Svendsen buffer, pH 8.8 (Weeke, 1973), with 1.5%
horse hyperimmune TBEV gamma-globulin (VNNI VS, Tomsk, Russia)
using an immunoelectrophoresis chamber (LKB). Viral antigens were
prepared by precipitation from infected cell culture supernatants with
10% PEG-6000 (Dzhivanian et al., 1991; Liapustin et al., 1987).
Samples in equal quantity (6–7 log10 PFU in infected cell culture ﬂuid)
of each virus were loaded on the anti-TBEV serum enriched agarose
gel, resolved at 7 V/cm for 12 h and stained with Coomassie Blue. RIE
experiments were repeated several times for each strain.
Modeling of the protein structures
Homology modeling was performed only for the soluble domain of
TBEV E proteins; stem-anchor domain was excluded from the
consideration. Amino acid sequence of the template protein was
extracted from the structure ﬁle from PDB (access code 1SVB (Rey et
al., 1995)). Amino acid sequences of the template (strain Neudorﬂ)
and targets were aligned in ClustalX 2.0.11 (Larkin et al., 2007) with
default parameters.
Homology modeling was performed by means of the program
MODELLER 9v5 (Šali and Blundell, 1993). Atomic coordinates of the
dimeric template were recreated from crystallographic data with
CCP4mg (Potterton et al., 2002). Thirty-ﬁve different models of the
dimeric soluble domains were built for viruses Absettarov 18A,
SofjinKGG, and 80k, and the simulated annealing procedure was
applied to every model. The N-acetyl-D-glucosamine moiety attached
to Asn154 was kept intact. The best models based on the MODELLER
DOPE score and PROCHECK (Laskowski et al., 1993) validation score
were chosen for subsequent optimization.
Further optimization was performed for the models in SYBYL 8.0
(Tripos Inc., 1699 South Hanley Rd., St. Louis, Missouri, 63144, USA).
All hydrogen atoms were added, and then 150 steps of the Powell
minimization in the Tripos force ﬁeld were performed. Operations of
themolecules ﬁtting and comparisonwere performedwith SYBYL 8.0.
The ﬁnal structures of the models were used for molecular dynamics
studies.
Molecular dynamics (MD) simulation
Molecular dynamics simulation was performed by means of the
program complex AMBER 10 (Case et al., 2008). For the protein
molecule force ﬁeld AMBER ff99SB (Hornak et al., 2006) was used and
GLYCAM06 (Kirschner et al., 2008) was used for the carbohydrate
moiety. Atomic charges were automatically assigned in LeAP module
of the AMBER suite. The SHAKE algorithm (Ryckaert et al., 1977) was
applied to the lengths of the bonds containing hydrogen atoms to
reduce computational time. Generalized Born solventmodel (Tsui and
Case, 2001) was utilized to mimic solvent effects.
The energy of system was minimized prior to the production
dynamics run with 1500 iterations of steepest descent method and
1000 iterations of conjugated gradients method. Production MD run
was performed with sander on 256 processors of the supercomputer
SKIFMSU (Moscow State University Research Computing Center). The
following parameters were used: time step–2 fs (femtoseconds),
number of iterations–5million, system temperature was kept equal to
300 K by Langevin thermostat with collision frequency of 1 ps−1
(picoseconds).
271L.I. Kozlovskaya et al. / Virology 398 (2010) 262–272Visual analysis of trajectories was performed with VMD (Hum-
phrey et al., 1996); statistical analysis wasmade in ptraj module of the
AMBER suite. The principal component analysis of the trajectories was
also independently done with DYNAMITE web server (Barrett et al.,
2004).
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